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Stroke is among the top 10 causes of death in childhood. More than half of the surviving children have long-term neurological
sequelae. Ischemic stroke (IS) includes arterial ischemic stroke and cerebral venous thrombosis with venous infarction.
Haemorrhagic stroke (HS) includes intracerebral haematoma or subarachnoid haemorrhage. Risk factors for stroke are diﬀerent
in children and in adults. 10–30% of IS have no identiﬁed risk factors. However, multiple risk factors are recognizable in the
majorityofstrokeinchildren;thus,acomprehensivediagnosticevaluationiscrucial.Vascularabnormalities,suchasarteriovenous
malformations, aneurysms, vessel dissection, stenosis, and moyamoya disease, are frequently associated with both IS and HS and
lead to high recurrence rates. Endovascular and surgical treatment options are sometimes indicated, performed on the basis of
expert opinion, and extrapolated from the adult procedures. In the present paper, we review the recent literature and we discuss
the treatment in ﬁve cases managed at our institutions.
1.Introduction
In young population stroke is often an underestimated cause
of neurological disturbances with diﬀerent possible aetiolo-
gies and multiple treatment options. A thorough knowledge
of the pathophysiology of the disease, of the natural history
and of the possible diﬀerent therapies including medical
or surgical approaches, represents a necessary instrument
in order to obtain a prompt and correct diagnosis and
a successful recovery. Additionally, diagnosis of paediatric
stroke is even more diﬃcult, due to the limited expressive
and interpretive skills of symptoms compared to the adult
population.
Stroke is among the top 10 causes of death in childhood
with an incidence of 2–13 per 100,000 children. More than
half of the surviving children who had a stroke have long-
term neurological sequelae [1].
Ischemic stroke (IS) refers to both arterial ischemic
stroke(AIS)andcerebralvenousthrombosis(CVT)resulting
in venous infarction. Hemorrhagic stroke (HS) includes
intracerebral haemorrhage and nontraumatic subarachnoid
haemorrhage. Nearly half of paediatric strokes are hemor-
rhagic [2].
There are diﬀerences in the incidence of stroke during
childhood, with incidence rate of 3/100,000 under the age
of 1 year (even when neonatal or perinatal stroke, which is
knowntohaveaparticularlyhighincidencerate,isexcluded)
and of 0.7/100,000 at 5–9 years. Another incidence peak
is observed in male adolescents probably due to hormonal
factors [3].
The risk factors for childhood stroke are markedly
diﬀerent from those in adults, including young adults.
Childhood stroke in which no risk factors are identiﬁed
represent 10–30% of cases [3].
In the next paragraphs we try to give a schematic
presentation of the main risk factors for arterial, venous,
and haemorrhagic stroke, an overview about the stroke
outcome, and of the recurrence rate. In evaluating this
complex pathology, it is always important to consider that
thesameriskfactorcandetermineallthethreesituationsand2 Stroke Research and Treatment
that multiple factors can diﬀerently combine each others in
the same situation.
2. Risk Factors
2.1. Arterial Ischemic Stroke (AIS)
2.1.1. Arteriopathies. In childhood AIS, abnormalities of the
cerebral circulation (both intracranial and cervical) have
been reported in up to 80% of the cases [3]. The most
frequentlyidentiﬁed form of arteriopathy is termed transient
cerebral arteriopathy (TCA) or focal cerebral arteriopathy of
childhood (FCA), deﬁned as vascular stenosis not otherwise
classiﬁed as dissection, moyamoya, sickle cell arteriopathy
(SCA), postvaricella arteriopathy, vasculitis, or other speciﬁc
diagnoses. TCA or FCA represents a monophasic transient
arteriopathy aﬀecting large- or medium-sized vessels that,
on follow-up imaging few months after the infarct, generally
shows regression or nonprogression. It seems that many
cases of FCA have a postinfectious mechanism underlying
the arteriopathy, particularly recent upper respiratory tract
infections [3].
Craniocervical arterial dissection may be responsible
for 7 to 20% of childhood AIS. In children, the anterior
circulation is involved more frequently than the posterior
circulation. There is a history of trauma in half of the cases
althoughthetraumamaybeminor;inthesecasesthecervical
arteries are most commonly aﬀected, while intracranial
dissection accounts for at least a quarter of the cases. In
nontraumatic cases 60% of dissections are intracranial. In
dissecting diseases, symptoms can be related either to mass
eﬀect,ischemia,orSAH.Ifallvascularlayersoftheintradural
artery are dissected, a subarachnoid hemorrhagic will occur.
Intramural clot formation can cause distal thromboembolic
ischemia or occlusion of perforator branches and local
ischemia. Chronic dissecting process may eventually lead to
formation of a “giant partially thrombosed aneurysm” [4].
Unlike in the adult, an underlying condition predisposing
to dissection is seldom found in children. Recurrence rate is
about 10% [1, 3, 5].
Moyamoya is a noninﬂammatory nonatherosclerotic
vasculopathy. It is characterized by progressive occlusion or
stenosis of the cerebral vasculature particularly involving the
vessels feeding the circle of Willis, most commonly of the
distal internal carotid arteries, with compensation resulting
in the development of an extensive network of hypertrophic
arterial collaterals distal to the occlusion. Moyamoya can
be idiopathic (disease) or secondary (syndrome) when
associated with other causes of vasculopathy, such as sickle
cell disease (SCD), Down’s syndrome, neuroﬁbromatosis,
and previous cranial irradiation. Genetic polymorphisms
of HLA class II genes have been associated with idiopathic
moyamoya disease [6, 7].
Primary CNS vasculitis or systemic vasculitis (lupus
erythematosus, Henoch-Schonlein purpura, Wegener gran-
ulomatosis, polyarteritis nodosa, Takayasu arteritis, and
Kawasaki disease) have been linked to stroke.
Rare causes of cerebral arteriopathy in children include
neuroﬁbromatosis 1 (NF1) arterial dysplasia, postirradiation
arteriopathy, ﬁbromuscular dysplasia, and collagen disor-
ders.
2.1.2. Cardiac Diseases. Cardiac disease is one of the most
commonly identiﬁed risk factors in childhood IS, as it is
identiﬁed in 15–30% of cases of AIS.
In children with preexisting major congenital cardiac
malformations, embolic phenomena are the major cause of
stroke. Other factors involved include hypoxia, hypotension,
and polycytemia.
An association between IS and cardiac surgery or
catheterization is found in about 40% of children with
cardiac disease.
Patent foramen ovale (PFO) has been referred to as “the
back door to the brain” through which small venous thrombi
not ﬁltered by the pulmonary vasculature enter the systemic
circulation. In children and young adults with otherwise
cryptogenic stroke, an increased prevalence of PFO has been
found, even if there are not conclusive data demonstrating
causality [8].
Children with AIS may have both cardiac disease and
intracranial arteriopathy.
2.1.3. Haematological Disorders. In children with SCD the
risk of stroke is about 200 times greater than in other chil-
dren, and up to one-third of children with SCD have silent
strokes (neuroimaging evidence without history of stroke)
that frequently lead to cognitive deﬁcits. β-thalassemia can
also lead to IS.
Both of these conditions can cause stroke because of
anemia and hypercoagulable state. Moreover, development
of stenosis of the intracranial internal carotid artery (ICA)
and of the proximal middle cerebral artery (MCA) in SCD
determines a secondary moyamoya like vasculopathy due to
repeated insults on the vessels’ walls.
Iron-deﬁciency anaemia has been found to be present in
20% of previously healthy children with AIS.
A number of genetic thrombophilic traits have been
associated with paediatric stroke: prothrombin G20210A,
factor V Leiden G1691A, MTHFR C677T, lipoprotein(a),
antiphospholipid antibodies/LLAC, protein S deﬁciency,
antithrombin deﬁciency, protein C deﬁciency, diﬀerent hap-
lotypes of genes involved in the nitric oxide pathways and
thus in possible endothelial impairment.
2.1.4. Infections. CNS infections, that is, meningitis and
encephalitis, are present in 10% of cases of AIS, presumably
due to vascular inﬂammation and thrombosis or due to
reduced cerebral perfusion secondary to systemic hypoten-
sion, raisedintracranial pressure,andlow cerebrospinalﬂuid
glucose.
Hypotension and hypercoagulable state as a consequence
of bacteraemia or sepsis can lead to IS.
Focal cerebral artery stenosis with a history of varicella
infection in the preceding year has been termed post-
varicella angiopathy, thought to be due to viral invasion of
the artery wall as already mentioned in the previous section
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The most common risk factor identiﬁed in childhood
stroke due to CVT is represented by middle-ear and
paranasal sinus infections.
2.1.5. Genetics. An increased risk of stroke has been asso-
ciated with numerous genetic diseases, such as the above-
mentioned SCD and genetically inherited thrombophilic
traits, Down’s syndrome, NF1, Williams syndrome, homo-
cystinuria, cerebral autosomal-dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL)
and Fabry disease, mitochondrial encephalomyopathy with
lactic acidosis and stroke (MELAS) [9].
AIS and CVT share many of the above-mentioned risk
factors.
2.2. Cerebral Sinovenous Thrombosis (CVT). CVT in child-
hood is a rare (incidence 0.4–0.7 per 100000 children
per year, most occurring within the neonatal period) but
underrecognized disorder, often of multifactorial aetiology,
with neurologic sequelae in up to 40% of survivors and
mortality approaching 10%. The spectrum of brain injury
varies from venous congestion to parenchymal ischemia
which may be cortical or subcortical and involve deep
grey matter. The majority of the parenchymal infarcts are
haemorrhagic. Subarachnoid and subdural haemorrhage are
less frequent. In neonates there is a strong association
between CVT and intraventricular haemorrhage. Infections
appear to be the most common condition associated to
CVT. Predisposing systemic comorbidity factors include
fever, infection, dehydration, anaemia, and chronic medical
conditions such as congenital heart disease, nephritic syn-
drome, autoimmune diseases, malignancy, and genetic and
acquired prothrombotic disorders. Moreover, locoregional
factors such as ﬁrst of all otitis media and mastoiditis, then
meningitis, head trauma, and recent intracranial surgery are
strongly related to CVT [10].
2.3. Haemorrhagic Stroke (HS)
2.3.1. Structural Lesions. Structural lesions account for at
least half of HS in children. Arteriovenous malformations
(AVMs) are the most commonly identiﬁed structural lesions
found in HS (30%), and 80% of the children with an AVM
will declare their malformation by HS. Probability of a ﬁrst
haemorrhage is 2–4% per year [11].
The vast majority of arterial cerebral aneurysms in the
paediatric age are symptomatic, and they account for 13%
of HS, mostly presenting with subarachnoid haemorrhage
(SAH). Aneurysms may be idiopathic (30%) or related to
arterial dissection (50%), to bacterial or mycotic infections
(15%), or to trauma (5–10%) [12]. In traumatic cases, HS
often presents 2–4 weeks after the head injury.
HS is also related to SCD (25% of ﬁrst strokes in children
with SCD are haemorrhagic) and moyamoya, due to fragility
of the dysplastic collateral vessels.
Cavernous malformations are found to be the cause of
bleeding in 15% of HS paediatric cases.
Finally, intratumoral haemorrhage can be a rare feature
of intracranial malignancy.
There is a threefold increased incidence of haemorrhage
in the posterior circulation in children compared to adults
and a ﬁvefold increased incidence in involvement of the
internal carotid artery termination [13, 14].
2.3.2. Haematological Disorders. Between 10 and 30% of
childhoodHSarecausedbyhaematologicaldisorderssuchas
haemophilia, thrombocytopenia, von Willebrand’s disease,
coagulopathy secondary to hepatic dysfunction, or vitamin
K deﬁciency [3].
About 25% of children have HS of undetermined cause.
3. Outcome
Fatality rates vary from 2 to 20% for IS and from 5 to 54%
for HS. Male gender, black ethnicity, and stroke recurrence
increase the risk of death. Neurological deﬁcits are reported
to be present in at least two-thirds of survivors.
Lesion location and extension is an important predictor
of outcome.
Even if it is widely believed that brain plasticity can
lead to improved outcome following acquired brain injury
at an early age, there is increasing evidence to support
the hypothesis that younger age at time of stroke is a
predictor of a worse outcome, particularly for cognitive and
neuropsychological domains [2, 3, 15, 16]. Mortality rate in
paediatric group is reported to be 6 to 30% [17]. Therefore,
children should be closely monitored over the time for
possible recurrences.
These are aspects that should be taken into consideration
also in children with silent infarctions.
4. Recurrence
Recurrence risk of AIS is about 1.2% in the perinatal age and
19% in later infancy and childhood, but probably a greater
number of children have TIAs or silent reinfarctions. Five-
year followup shows no recurrence in children with normal
vascular imaging and up to 60% recurrence rate in children
with vascular abnormalities [14].
HS recurrence rate is about 10% at 5-year followup.
No recurrences are expected in idiopathic HS whereas
13% recurrence rate in children with vascular structural
anomalies and in those with medical causes of HS; in the
latter cases, recurrence tends to occur within the ﬁrst week,
while in the former it may occur years later [18].
Between 10% and 20% of children who have a CVT will
experience a recurrent symptomatic venous event, half of
which systemic rather than cerebral [10].
5.DiagnosticImaging
Cerebral imaging includes computed tomography (CT)
particularly when HS is suspected in order to rapidly
discriminate between HS and IS and to distinguish between
intracerebralhaematomaorSAH.Magneticresonanceimag-
ing (MRI) with angio-MR (MRA) helps to precisely identify
the site of IS/HS, the involved structures, the presence of
oedema, and/or mass eﬀects. Diﬀusion MR (DWI) and4 Stroke Research and Treatment
(a) (b)
Figure 1: MRA (a) and MRI sagittal sections (b), obtained 11 days after the initial symptoms, demonstrate the presence of a BA aneurysm
with mass eﬀect on the pons (arrowheads in (b)) and ischemic changes (not shown). At both edges of the aneurysm, stenosis of the BA is
recognizable (arrows in (a)).
perfusion MR (PWI) are useful to evaluate the timing of
the stroke and the cerebral blood ﬂow in the surrounding
areas. Gradient-echo and susceptibility-weighted images MR
(GRE/SWI) are able to detect deoxyhaemoglobin in very
recent bleeding when other sequences are unable to demon-
stratethe extent of the haematoma or to detect smallamount
of haemosiderin in old HS or in cryptic malformations,
such as cavernous angiomas. Finally, in selected cases, digital
subtraction cerebral angiography (DSA) is recommended to
better evaluate the vascular tree. Speciﬁcally, dedicated cere-
brovascular imaging with DSA is crucial when no cause for
stroke is found via noninvasive vascular imaging. Sometimes
vascular malformations are not immediately evident after
the acute haemorrhage; therefore, when vascular imaging is
normal or inconclusive, the studies should be repeated once
the clot has been reabsorbed [1, 3, 14, 18].
6. Treatment
Three consensus papers suggest the guidelines for the eval-
uation and treatment of AIS in childhood [15, 19, 20], and
one encompasses guidelines for the treatment or evaluation
of paediatric HS [20].
6.1. Medical Treatment. Acute and chronic management of
IS includes several options, depending on the aetiology
of stroke, timing, extent, and so forth. Antioedema and
antiplatelet treatments are often indicated. Anticoagulant
therapies are usually employed in cardiac cause, CVT,
dissection,andrecurrentstrokewhileonantiplatelettherapy.
Exchange transfusion (SCD), cerebral and systemic support-
ive care, and correction of speciﬁc conditions are always
required. Paediatrics encompasses a wide range of ages with
maturational diﬀerences. Optimal dosing is likely to diﬀer as
there are age-dependent diﬀerences in haemostasis, younger
individuals demonstrating diminished speciﬁc indices of
ﬁbrinolysis and global, increased ﬁbrinolytic capability [17].
 
Figure 2:Follow-upangiogram,obtained11monthsaftertheonset
of symptoms, shows complete obliteration of the BA at the level
of the dissection, without any evidence of residual ﬁlling of the
aneurysm.
CVT treatment includes general supportive measures
and antithrombotic and nonantithrombotic therapies. Anti-
coagulant and antiplatelet treatment regimens vary between
centers, and some of them prefer unfractioned heparin in
the acute state, as the eﬀects of heparin can be reversed
if intracranial haemorrhage occurs. In the following 3 to
6 months, chronic anticoagulation is maintained with Low
Molecular Weight Heparin (LMWH) or Coumadin [10].
Treatment of neonates with LMWH appears to be safe and
should at least be considered. There are very few reportsStroke Research and Treatment 5
(a) (b)
Figure 3: MRI coronal FLAIR (a) and axial T2-weighted (b) images show an infarction in the left superior cerebellar hemisphere, in the
territory of one hemispheric branch of the left SCA.
(a) (b)
Figure 4: MRI axial T2-weighted (a) and diﬀusion-weighted (DWI) (b) images demonstrate the old infarction in the left superior cerebellar
hemisphere and the new lesion in the right superior cerebellar hemisphere with identical distribution. The restricted diﬀusivity (high signal
intensity in (b)) indicates a recent infarction.
on the use of antiplatelet agents such as acetylsalicylic acid
(ASA) or dipyridamole in the acute or chronic settings in
paediatricage[10].IfsigniﬁcantICHisassociatedwithCVT,
the use of anticoagulants is controversial. Septic situation
requires antibiotics and may need surgical removal and
drainage of the infection. Medical treatment of HS is mainly
supportive, with correction of treatable haemorrhage risk
factors or correction of speciﬁc conditions such as, for
instance, antimicrobial treatment in infectious aneurysms.
While a neuroprotective role has been ascribed to hyper-
tonicsolutionsofalbumin,memantineHCl,andmagnesium
sulphate that are recommended for the treatment of adult
ischemic stroke patients, no data are available in order
to make recommendations regarding use in paediatric AIS
[17].
6.2. Surgical Options. Within the management of paediatric
stroke, invasive treatments are rarely performed in selected
cases, based on expert opinion [11, 12, 16, 21–27].
Surgical revascularization procedures include direct sur-
gical bypass or indirect procedures to encourage develop-
ment of collateral blood vessels such as the encephalo-
duroarteriomyosinangiosis in moyamoya. In case of massive
cerebellar oedema or haematoma, decompressive craniec-
tomy and haematoma evacuation can be performed to
prevent tonsillar herniation. Decompressive surgery is6 Stroke Research and Treatment
Figure 5: MRI axial T2 weighted shows the cortical-subcortical
abnormalities in the left temporo-parietal-occipital region.
required in supratentorial large cerebral lesions with mass
eﬀect and transtentorial herniation. In hydrocephalus, after
intraventricular haemorrhage or SAH, external ventricular
drainage may be required. In vascular malformations such
as aneurysms or AVMs, open surgery represents a possible
treatment.
6.3. Endovascular Options. The endovascular options in
case of IS comprise (1) intra-arterial thrombolysis and/or
mechanicalrevascularization in thromboembolic lesions, (2)
revascularization procedures with stenting with or without
angioplasty in stenoses or dissections, and (3) intra-arterial
administration of vasodilator drugs in vessels spasm. In
cases of HS due to bleeding from vascular malformations,
endovascular repair with platinum detachable coils or ﬂow
diverter for aneurysms, and histoacrylic or polymeric glue
injections in AVM are possible alternatives. In selected cases,
surgical and endovascular approaches can be combined.
An additional option for the treatment of small AVM is
represented by radiosurgery [28]. In case of cardiac disease
(i.e., PFO), correction of the cardiac defect should be
considered.
7. IllustrativeCases
7.1. Case 1 (Figures 1 and 2). A 15-year-old female patient
was admitted to our hospital for angiographic followup
and possible treatment of a partially thrombosed basilar
artery (BA) dissecting aneurysm extending from the mid-
basilar portion to the origin of the superior cerebellar
arteries (SCAs). One week before her ﬁrst hospitalization the
patient had complained of sudden nuchal headaches some-
times associated with nausea, vomiting, and visual changes,
which disappeared without any treatment. No history of
previous trauma was reported. Physical and neurological
examinationswerewithinnormallimits.Four-vesselcerebral
digital subtraction angiography (DSA) and MRA (Figure 1)
demonstrated the presence of the BA aneurysmal dilatation
measuring 5mm in its patent portion with an extension of
2cm in length. Stenosis of the BA was recognizable proximal
and distal to the aneurysm (Figure 1). Both SCAs were
injected from the BA. MR imaging also visualized small
ischemic areas in the left lower part of the pons and in the
left cerebral peduncle (Figure 1). The patient was discharged
on antiplatelet therapy (ticlopidine 250mg/dL) to prevent
further thrombotic events. The 2- and 4-month follow-
up MR imaging with MRA showed further progression of
the BA stenosis. Due to the good clinical condition of the
patient, endovascular revascularization was not performed
because of the high procedural risks. Finally, the follow-up
angiogram (Figure 2) obtained 11 months after the initial
symptoms demonstrated complete obliteration of the BA at
the level of the dissection (arrows) without any evidence
of ﬁlling of the aneurysmal pouch and adequate collateral
ﬂow to the upper BA, posterior cerebral arteries (PCAs),
and SCAs provided by the internal carotid arteries via the
posterior communicating arteries. MR imaging performed
at the same time demonstrated shrinkage of the aneurysm
without new ischemic lesions. The 19-month follow-up MR
imaging ruled out the presence of new ischemic areas. At
the present time, 6 years later, the patient remains clinically
stable and neurologically intact. The extensive workup for
suspected collagenopathy, including genetic research for the
type 4 Ehlers-Danlos and collagen biopsy, was negative.
7.2. Case 2 (Figures 3 and 4). A 7-year-old roller-skater male
was ﬁrst admitted at a primary medical center with a 4-
hour history of acute onset of unstable gait and left-limb
weakness during a play ﬁght with his sister, followed by
diﬀuse headache. A brain CT scan was normal. Over the
next 12 hours the patient’s balance disorder improved, while
left-limb weakness remained stable and a mild left cerebellar
syndrome. Brain MRI and magnetic resonance angiography
(MRA) showed a left cerebellar ischemic stroke and absence
of the left superior cerebellar artery (SCA). Cardiac disorders
were initially excluded by transthoracic echocardiogram.
The patient was admitted to our institute 5 days after
symptoms onset. Anti-platelet treatment was started. Head
and neck angio-CT and brain MRI revealed an infarction
in the left superior cerebellar hemisphere (Figure 3) and the
presence of a possible dissection of the left vertebral artery
close to the foramen magnum. The cerebral DSA showed a
lumen margin irregularity consistent with a fresh thrombus
in the proximal tract of the left SCA. Laboratory ﬁndings
excluded haematological disorders such as thrombophilias
and SCD.
Over the next 7 days the patient’s neurological symptoms
gradually improved. Then, one week later, he abruptly
developed headache, repeated vomiting, disturbance of
consciousness with drowsiness, and right limb weakness.
Brain MRI demonstrated a new cerebellar ischemic lesion
in the superior right cerebellar hemisphere (Figure 4).
Anticoagulant medication (low molecular weight heparin)
was initiated. Over the following days the patient hadStroke Research and Treatment 7
(a) (b)
Figure 6: Anteroposterior view of the left vertebral angiography showing a direct arteriovenous shunt between the anterior temporal branch
of the left PCA (white arrow) and a superﬁcial temporal vein with an interposed irregular aneurysmal dilatation (black arrow in (a)).
The posttreatment angiography (b) demonstrates the complete resolution of the shunt obtained utilizing detachable platinum coils and
h i s t o a c r y l i cg l u e( a r r o wi n( b ) ) .
Figure 7: A small, well-deﬁned hyperdense lesion in the left
frontal basal area, just below the basal nuclei, is recognizable at
the emergency CT (arrow). There is no evidence of subarachnoid
haemorrhage.
a dramatic clinical improvement, and neurological exami-
nation demonstrated only a mild right cerebellar syndrome.
Repeated transoesophageal echocardiography during Val-
salva maneuver revealed an atrial septal defect that was
repaired via percutaneous endovascular approach due to
signiﬁcant resting shunts. Clinical and neuroradiological
followups since then were unremarkable.
7.3. Case 3 (Figures 5 and 6). A 4-year-old female, with a
strong family history (father and grandfather) of hereditary
hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber
disease, was ﬁrst evaluated at our institute at the age of
3monthsforlefttemporallobehemorrhagiclesionsdetected
elsewhere in the neonatal period. Neonatal history was
complicated by tremors and generalized seizures that started
ontheseconddayoflifeafternormalpregnancyanddelivery.
On ﬁrst admission at our institute, she was severely
hypotonic; epilepsy was well controlled by antiepileptic
monotherapy. Serial brain MRI and MRA studies (Figure 5)
revealed left cortical-subcortical temporo-parietal-occipital
gliotic-malacicareasassociatedwithacorticalmalformation.
A possible vascular malformation was also suspected in
the left temporal hemisphere. Due to the age and the clinical
condition of the patient, DSA was not performed at that
time.
The patient presented psychomotor and language delay,
and at the age of 4 years she started having recurrent
episodes of epistaxis. Genetic analysis conﬁrmed the HHT
diagnosis with a mutation in the endoglin gene (ENG) on
chromosome 9. Abdominal and pulmonary artero-venous
malformations were excluded after adequate screening.
Four vessels DSA was then performed under general
anesthesia, showing a left temporal arteriovenous shunt with
an abnormal vascular dilatation, probably consistent with
av e n o u sv a r i x( Figure 6(a)). It was successfully treated via
endovascular approach with a superselective catheterization
of the left anterior temporal artery, obliterating the venous
varix and the shunt, utilizing detachable platinum coils and
histoacrylic glue (Figure 6(b)).
7.4. Case 4 (Figures 7 and 8). A 12-year-old girl, who
complained of a sudden headache with no other neuro-
logical deﬁcit, was brought to the Emergency Room of
another hospital. CT scan showed a small, round area of
hyperdensity in the left basal frontal lobe, just below the
basal ganglia (arrow in Figure 7). No subarachnoid blood
was depicted. The patient was referred to our hospital for
further examinations. At admittance, the patient was awake,
well oriented, with no neurological deﬁcit, but suﬀering8 Stroke Research and Treatment
(a) (b)
Figure8:Anteroposteriorviewoftheleftinternalcarotidarteryangiographyshowsablister-likeaneurysmattheintracranialbifurcation(a).
Notethesmallpseudoaneurysm(arrowin(a))atthedomeoftheaneurysmalsac,correspondingtotheimageseenontheCT(Figure 7),and
the spasm in the supraclinoid portion of the carotid artery. The posttreatment angiography shows successful obliteration of the aneurysm
with stent and a single platinum coil (b).
Figure 9:CTatadmittancetoEmergencyRoomshowsahyperden-
sity of the basilar artery, consistent with a thrombus (arrow).
from intense headache. DSA showed a small “blister-like”
aneurysm at the left internal carotid artery bifurcation with
a pseudoaneurysm just above it (arrow in Figure 8(a)). The
patient was treated by endovascular approach, considering
the neurosurgical approach more risky due to the presence
of many perforating vessels in the area. Since the neck of the
aneurysm was wide, a neuroform stent was deployed and a
singleplatinumcoildetachedafterpassingthroughthestruts
of the stent. The ﬁnal control showed the occlusion of the
sac and the normal ﬂow in the carotid artery (Figure 8(b)),
with contrast stagnation inside the pseudoaneurysm. After
Figure 10:TheaxialT2MRstudyperformed3daysaftersymptoms
onset demonstrates the ischemic lesions in the pons and right
occipital cortex.
the stent deployment, antiplatelet therapy was started and
kept for 6 weeks. The patient had no deﬁcit. Headache
progressively decreased in the following days.
No recurrence of the aneurysm was observed at the 6-
month follow-up angiography.
7.5. Case 5 (Figures 9–11). A 3-year-old African boy pre-
sented with sudden onset of nausea and vomiting. He was
admitted to the Emergency Room hypotonic, hyporeactive,
with abnormal ocular movements and recurrent seizures. In
the recent past medical history, only sporadic headache wasStroke Research and Treatment 9
reported,afteravaricellainfection.AtbrainCTahyperdense
basilar artery was visible (arrow in Figure 9). At MRI with
MRA, ischemic lesions in the vertebrobasilar territory with
severe obstruction of the basilar and right posterior cerebral
arteries were observed. As some hours had already passed
from symptoms onset and the experience as well as the
literature data on thrombolysis in children were poor, it was
decided not to proceed to thrombolysis neither by venous
nor arterial route. In addition, clinical conditions, though
severe, did not seem to be life-threatening at that moment.
Over the next few days, patient clinical conditions slowly but
progressively improved. An MRI control at day 3 showed
a new lesion in the pons (Figure 10). A DSA performed at
day 12 conﬁrmed the MRI ﬁndings: occlusion of the basilar
artery from the vertebrobasilar (VB) junction to the tip, with
good collaterals supplying the brainstem perforators and
partial revascularization of the superior cerebellar arteries
(arrows in Figure 11).
In the diagnostic workup, a patency of the foramen
ovale was found, as the cardiologists did not consider the
thromboembolic source causing the occlusion. At day 22, at
discharge, no neurological deﬁcits were present except for a
veryslightdiﬃcultyinwalkingwithapreferreduseoftheleft
limbs.
8. Discussion and Conclusion
Stroke in paediatric population is associated with relative
high morbidity, mortality, and recurrence rates. Silent stroke
can be responsible for neuropsychological disability not
otherwise recognizable.
If a stroke is suspected in a child, the diagnostic work-
up should include systemic blood tests (haematological
disorders, infections), genetic and cardiac examinations (see
our case 2). The neuroradiological diagnosis comprehends
CT scan, MR imaging, and DSA. CT scan may demonstrate
the presence and site of the intracranial bleeding (SAH or
intracerebral haematoma) in case of HS. MR imaging with
MRA better delineates the brain tissue status, the presence,
the nature, and sometime the timing of possible structural
lesions, for both HS and IS. They represent crucial tools
bothfortreatmentplanningandfollowup.DSAisaninvasive
exam that should be performed by expert operators and only
in selected cases. MRI and DSA in childhood are commonly
performed in general anaesthesia to ensure a good quality
imaging without any discomfort for the young patient.
In the appropriate setting, besides medical treatment,
invasive procedures including endovascular approach should
be considered. In cases of structural lesions a thorough
risk/beneﬁt analysis in order to decide the best treatment
option is mandatory. Timing of invasive treatment can also
represent a troublesome factor in a very young patient in
whom ﬂuid balance is a critical aspect in the anesthesiologi-
cal and surgical management. In very small children, for this
reason, it may be necessary to delay treatment waiting for a
more favourable clinical status such as in our case 3.
In case of aneurysm the endovascular approach includes
the obliteration of the fundus utilizing detachable coils
associated with an intracranial stent in case of large neck,
∗
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Figure 11: Cerebral angiography (lateral view) with injection of
the left vertebral artery (arrow) shows occlusion of the basilar
artery (open arrow) at the vertebrobasilar junction, just above the
origin of the right superior cerebellar artery (white arrowhead).
There are many tiny collaterals that supply the territory of the
brainstem perforators (small arrowheads) and wider collaterals that
reconstitute the superior cerebellar artery (asterisks). There is also
retrograde ﬁlling of the right vertebral artery (white arrows) and of
the right PICA.
such as in our case 4. Experience in stent placement in
childrenislimited;doubleantiplatelettherapyincaseofstent
deployment is recommended; since there are not speciﬁc
trials for antiplatelet treatment for intracranial stenting in
children,medicaltreatmentisreasonablybasedontheadult’s
literature data. Another concern with paediatric intracranial
stenting is the ongoing growth of the vessels over the time
[11, 12, 23].
Dissecting aneurysm represents a typical vascular mal-
formation in which the treatment must be tailored case by
case.Incaseofalargedissectinganeurysminadistalvascular
territory, the obliteration of the arterial feeder with coils or
glue should be taken into consideration. A balloon occlusion
testtoverifythepossiblecollateralnetworkcanbepreviously
performed.Incaseofalargethromboticdissectinganeurysm
in a vital territory, a precise preoperatory planning should
be carried out, balancing beneﬁts and risks. In our case 1,
where a nonruptured large partially thrombosed aneurysm
of the basilar artery causes a critical stenosis of the vessel,
we preferred to delay the management of the aneurysm
and of the BA stenosis because of the good clinical con-
dition of the patient. Therefore, we followed the patient
with MRI and MRA every 2–4 months. The spontaneous
occlusion of the BA with repair of the aneurysm occurred
asymptomatically.
Detachable coils and glue can be successfully utilized to
occlude arteriovenous ﬁstulas or AVM, such as in our case
3 in whom the direct AV ﬁstula was related to HHT; in fact
the presence of a cerebral AVM is one of the four diagnostic
criteria for HHT [27].10 Stroke Research and Treatment
In childhood, revascularization procedures in throm-
botic vessels utilizing an endovascular approach are anec-
dotic (our case 5), likewise for the new ﬂow-diverters devices
that are indicated for aneurysmal repair in adult, and no
literature data or speciﬁc recommendations are available as
already discussed in the Treatment section.
In conclusion, stroke in childhood represents a chal-
lenging disease in which a correct diagnostic conduct may
lead to the most appropriate treatment. A decision-making
processshouldbecarriedoutcasebycasebyamultispecialist
group, including the neuropaediatrician, neurosurgeon, and
neuroradiologist. Future trials focused on treatment of
vascular diseases in the youngest population are necessary to
better understand the disease and, therefore, to improve the
treatment.
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